Clinical trials by country
Phase III trials
Austria
Bulgaria
Belgium
Czech Republic
Denmark
Finland
France
- INFRONT-3 (planned)
- LO-MAPT
- 17-AVP-786-305
Germany
Hungary
Italy
Netherlands
Poland
Portugal
Spain
Sweden
Switzerland
UK
Last Updated: Wednesday 21 April 2021